By Dr Carlos Velez, expert-trainer of Business Development & Licensing Course For Pharma & Biotech.
Innovation starts in the lab, but success depends on many factors: scientific excellence, execution, funding, and timing among them.
One capability that connects these elements and helps turn innovation into measurable value is business development and licensing (BD&L).
BD&L is often viewed as a final step in the process: the team that negotiates, signs agreements, and announces partnerships.
In reality, BD&L is a strategic capability that links science, finance, and corporate vision. It shapes how companies decide which assets to advance, who to partner with, and how to balance risk and reward across the portfolio.
When applied strategically, BD&L brings together diverse perspectives to answer key questions:
A mature BD&L capability blends multiple disciplines:
These elements rely on collaboration across functions, from R&D and finance to commercial, legal, and leadership teams.
No company succeeds on science alone.
As the industry becomes more interconnected, understanding the principles of business development helps teams across roles make better, faster, and more strategic decisions.
Building internal BD&L capabilities strengthens collaboration, enhances valuation discussions, and increases readiness for future opportunities.